h
PSC
reg
®
Home
Browse
All cell lines
All hiPSC lines
All hESC lines
Cell line providers
Research projects
Countries
Diseases
Publications
Clinical studies
Info
About hPSCreg
FAQ
Cell Registration
Glossary
Documents & Governance
Fact Sheets
Naming Tool
Publishing your line
Structures
Registration Summary
Certification
Organoids
API
Export Data
SPARQL Guide
Contact
News
Newsletter Subscription
Privacy Policy
Terms of Use
Imprint
Login
Log-in
Sign up
Forgot your password?
This website uses cookies to keep track of login sessions and for internal Matomo Statistics. See our
Privacy Policy
for details.
This website uses cookies,
learn more
x
UALGi001-A
Registration Summary
:
A
P
E
C
VITAL16
The cell line is
not submitted
yet.
(only basic data is shown)
General
Cell Line
hPSCreg name
UALGi001-A
Cite as:
When citing this cell line, please use the hPSCreg name (see
Naming Tool
) and the corresponding Research Resource ID (RRID).
UALGi001-A (RRID:CVCL_A7IV)
Alternative name(s)
VITAL16
Cell line type
Human induced pluripotent stem cell (hiPSC)
Similar lines
No similar lines found.
Last update
22nd March 2021
User feedback
show/hide
Written by
on
Delete
No feedback available yet.
Login
to share your feedback, experiences or results with the research community.
Provider
Generator
Universidade do Algarve (UALG)
External Databases
Cellosaurus
CVCL_A7IV
Wikidata
Q107117186
General Information
Publications
Calado SM et al. Generation of a human induced pluripotent stem cell line (UALGi001-A) from a patient with Left-Ventricular Noncompaction Cardiomyopathy. Stem cell research. 2021 May;53:102302.
Calado SM et al. Generation and cardiac differentiation of a human induced pluripotent stem cell line UALGi002-A from a female patient with Left-Ventricular Noncompaction Cardiomyopathy. Stem cell research. 2021 Aug;55:102462.
Correia Cátia D. et al. Human Stem Cells for Cardiac Disease Modeling and Preclinical and Clinical Applications—Are We on the Road to Success?. Cells. 2023-06-27.
Yuan He-Ling et al. Application and challenges of stem cells in cardiovascular aging. Regenerative Therapy. 2024-03-00.
* Is the cell line readily obtainable for third parties?
No
hIPSC Derivation
General
Login to share your feedback, experiences or results with the research community.